Literature DB >> 8904441

Factors influencing the vitek gram-positive susceptibility system's detection of vanB-encoded vancomycin resistance among enterococci.

B Jett1, L Free, D F Sahm.   

Abstract

Studies were conducted to identify factors contributing to the inability of the Vitek Gram-Positive Susceptibility system (GPS; bioMerieux, Vitek, Inc., Hazelwood, Mo.) to reliably detect vanB-mediated vancomycin resistance among enterococci. To some extent the accuracy of the GPS depended on a particular strain's level of resistance, as all isolates for which vancomycin MICs were > or = 128 mu g/ml were readily detected but detection of resistance expressed by several strains for which MICs were < or = 64 mu g/ml was sporadic. Factors besides the level of resistance were studied in two vanB strains. For one strain (Enterococcus faecium U8304), the ability of GPS to detect resistance was accurate and consistent, while for the other (Enterococcus faecalis V583), GPS results were inconsistent and unreliable. Using these isolates, we established that growth medium had the most notable effect on the detection of resistance. In the absence of vancomycin, Vitek GPS broth supported growth comparable to that obtained with brain heart infusion broth for both E. faecium U8304 and E. faecalis V583. However, in the presence of vancomycin the growth patterns changed dramatically so that neither VanB strain grew well in Vitek broth, and growth of V583 was barely detectable after 8 h of incubation. In contrast, good growth of both strains was observed in brain heart infusion broth supplemented with vancomycin. Additionally, the same medium effect was observed with other inducibly resistant VanB strains. In conclusion, although Vitek broth can support good enterococcal growth, this medium does not sufficiently support expression of vancomycin resistance by certain strains to allow them to be detected by the Vitek automated system. Furthermore, this observation establishes that the type of growth medium used can substantially influence the expression of vancomycin resistance and indicates that medium-based strategies should be explored for the enhancement of resistance detection among commercial systems.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8904441      PMCID: PMC228873          DOI: 10.1128/jcm.34.3.701-706.1996

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  19 in total

1.  In vitro detection of enterococcal vancomycin resistance.

Authors:  D F Sahm; L Olsen
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

2.  Identification of Enterococcus species isolated from human infections by a conventional test scheme.

Authors:  R R Facklam; M D Collins
Journal:  J Clin Microbiol       Date:  1989-04       Impact factor: 5.948

3.  Detection of vancomycin resistance in Enterococcus species.

Authors:  B M Willey; B N Kreiswirth; A E Simor; G Willaims; S R Scriver; A Phillips; D E Low
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

4.  In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis.

Authors:  D F Sahm; J Kissinger; M S Gilmore; P R Murray; R Mulder; J Solliday; B Clarke
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

5.  The vanB gene confers various levels of self-transferable resistance to vancomycin in enterococci.

Authors:  R Quintiliani; S Evers; P Courvalin
Journal:  J Infect Dis       Date:  1993-05       Impact factor: 5.226

6.  New vancomycin disk diffusion breakpoints for enterococci. The National Committee for Clinical Laboratory Standards Working Group on Enterococci.

Authors:  J M Swenson; M J Ferraro; D F Sahm; P Charache; F C Tenover
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

7.  Vancomycin resistance is encoded on a pheromone response plasmid in Enterococcus faecium 228.

Authors:  S Handwerger; M J Pucci; A Kolokathis
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

8.  The vanB gene of vancomycin-resistant Enterococcus faecalis V583 is structurally related to genes encoding D-Ala:D-Ala ligases and glycopeptide-resistance proteins VanA and VanC.

Authors:  S Evers; D F Sahm; P Courvalin
Journal:  Gene       Date:  1993-02-14       Impact factor: 3.688

9.  Effects of amino acids on expression of enterococcal vancomycin resistance.

Authors:  L J Zarlenga; M S Gilmore; D F Sahm
Journal:  Antimicrob Agents Chemother       Date:  1992-04       Impact factor: 5.191

10.  Inducible and constitutive expression of vanC-1-encoded resistance to vancomycin in Enterococcus gallinarum.

Authors:  D F Sahm; L Free; S Handwerger
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191

View more
  7 in total

1.  Use of molecular and reference susceptibility testing methods in a multicenter evaluation of MicroScan dried overnight gram-positive MIC panels for detection of vancomycin and high-level aminoglycoside resistances in enterococci.

Authors:  Y S Chen; S A Marshall; P L Winokur; S L Coffman; W W Wilke; P R Murray; C A Spiegel; M A Pfaller; G V Doern; R N Jones
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

Review 2.  Expert systems in clinical microbiology.

Authors:  Trevor Winstanley; Patrice Courvalin
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

3.  Detection of vancomycin-resistant enterococci in fecal samples by PCR.

Authors:  S Satake; N Clark; D Rimland; F S Nolte; F C Tenover
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

4.  Semisynthetic glycopeptide antibiotics derived from LY264826 active against vancomycin-resistant enterococci.

Authors:  T I Nicas; D L Mullen; J E Flokowitsch; D A Preston; N J Snyder; M J Zweifel; S C Wilkie; M J Rodriguez; R C Thompson; R D Cooper
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

5.  Comparison of inhibitory and bactericidal activities and postantibiotic effects of LY333328 and ampicillin used singly and in combination against vancomycin-resistant Enterococcus faecium.

Authors:  A L Baltch; R P Smith; W J Ritz; L H Bopp
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

6.  Prevalence of Vancomycin-Resistant Enterococcus (VRE) in Companion Animals: The First Meta-Analysis and Systematic Review.

Authors:  Yusuf Wada; Ahmad Adebayo Irekeola; Engku Nur Syafirah E A R; Wardah Yusof; Lee Lih Huey; Suwaiba Ladan Muhammad; Azian Harun; Chan Yean Yean; Abdul Rahman Zaidah
Journal:  Antibiotics (Basel)       Date:  2021-01-31

7.  Direct Identification, Antimicrobial Susceptibility Testing, and Extended-Spectrum β-Lactamase and Carbapenemase Detection in Gram-Negative Bacteria Isolated from Blood Cultures.

Authors:  Hainan Wen; Shoujun Xie; Yueyi Liang; Yanchao Liu; Honglian Wei; Qian Sun; Weigang Wang; Baojiang Wen; Jianhong Zhao
Journal:  Infect Drug Resist       Date:  2022-04-06       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.